No Detail Found!

Discovery of Novel Alanine Racemase Inhibitors Through Cheminformatics and Biophysical Approaches

Author(s)
Bilal Shaker Ewha Women University, Seoul, Republic of Korea.
Abstract
Antibiotic resistance in bacteria is rapidly increasing across the globe which warrants the development of new drugs to tackle this issue. Since alanine racemase is essential to bacterial survival, novel antibiotics could have efficacy targeting it, particularly in light of the growing prevalence of antibiotic resistance. This work employs cheminformatics and biophysics approaches to find and optimize new inhibitors of alanine racemase. The objective of the research is to effectively find strong inhibitors and advance the development of novel drugs to fight resistant bacterial infections by integrating virtual screening with molecular dynamics simulations. Herein, using clerodane furanolactones as a parent structure, we identified several derivatives of the compound to show the best binding with bacterial alanine racemase enzyme and block the biosynthesis of bacterial cell walls. Three compounds; Top-1, Top-2, and Top-3 with a binding affinity (in kcal/mol) of -8.7, -8.6, and -8.5, respectively were identified. The compounds were classified as good drug-like molecules as they clear parameters of Lipinski, Ghose Muegge, Vber, Egan, and MDDR drug-like rules. According to molecular dynamics simulation findings, the enzyme remained in good stable dynamics in the presence of compounds throughout the length of simulation time with average RMSD within the 3 Å range. Further observation noticed the enzyme residues in good overall stable behavior, particularly the active site residues. The intermolecular strength of interactions between the enzyme and compound was additionally cross-validated by binding free energy analysis. The net binding free energy (in kcal/mol) of Top-1, Top-2, and Top-3 is -22, -25.21, and -17, respectively in the MM-GBSA method and -32.14 (Top-1),-29.45 (Top-2) and -32.87 (Top-3) in WaterSwap. Together this study indicated the screened compounds as promising antibacterial and might be investigated in the experimental analysis for biological activity.
Publication Details
Page(s) 1-12
Published Journal: Abasyn Journal of Life Sciences, Volume: 7, Issue: 2, Year: 2024

Request the full text from PASTIC

Keywords
molecular docking, Auto-Dock Vina, Alanine Racemase, Molecular Dynamic simulation, Water Swap
References
Tacconelli ,Magrini N.,Kahlmeter G.,Singh N. .2017 .Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. World Heal. Organ, 27 : .
Tacconelli ,Carrara E.,Savoldi A.,Harbarth S.,Monnet M.,Pulcini D.L.,Kahlmeter C.,Kluytmans G.,J. G.,Y. G. .2018 .Development of New Antibiotics: The WHO Priority List of Antibiotic-Resistant Bacteria and Tuberculosis. Lancet Infect. Dis, 18 : 318-327.
Myers A.G. .2021 .Discovery of Macrolide Antibiotics Effective against Multi-Drug Resistant GramNegative Pathogens. Acc. Chem. Res, 54 : 1635-1645.
Mendelson M.,Matsoso M.P.,The World Health Organization Global Action M.P. .2015 .SAMJ South African Med. , 105 : 325.
Morehead M.S.,Scarbrough C. .2018 .Emergence of Global Antibiotic Resistance. Prim Care, 45 : 467-484.
Rather I.A.,Kim B.-C.,Bajpai V.K.,Park Y.-H.,Self-Medication Current,Challenges Current,Prevention Current .2017 .. Saudi J. Biol. Sci, 24 : 808-812.
Gould I.M. .2008 .The Epidemiology of Antibiotic Resistance. Int. J. Antimicrob. Agents, 32 : S2-S9.
Ventola C.L. .2015 .The Antibiotic Resistance Crisis: Part 1: Causes and Threats. Pharm. Ther, 40 : 277.
Otto M. MRSA .2012 .Virulence and Spread. Cell. Microbiol, 14 : 1513-1521.
Shlaes D.M.,Sahm D.,Opiela C.,Spellberg B. .2013 .The FDA Reboot of Antibiotic Development. Antimicrob. Agents Chemother, 57 : 4605-4607.
.2016 .. , 10 : 7.
Macalino S.J.Y.,Gosu V.,Hong S.,Choi S. .2015 .Role of Computer-Aided Drug Design in Modern Drug Discovery. Arch. Pharm. Res, 38 : 1686-1701.
Pettersen E.F.,Goddard E.F.,Huang C.C.,Couch G.S.,Greenblatt D.M.,Meng E.C.,Ferrin T.E.,UCSF T.E. .2004 .Chimera-a Visualization System for Exploratory Research and Analysis. J. Comput. Chem, 25 : 1605-1612.
Naas T.,Oueslati S.,Dabos R.A.,Zavala M.L.,Dortet A.,Retailleau L.,Iorga P.,Database (BLDB)--Structure B.I. BetaLactamase .2017 .. J. Enzyme Inhib. Med. Chem, 32 : 917-919.
Zhang ,Transpeptidase .2009 .. Am. J. Respir. Cell Mol. Biol, 41 : 509-515.
Azam M.A.,Jayaram U. .2016 .Inhibitors of Alanine Racemase Enzyme: A Review. J. Enzyme Inhib. Med. Chem, 31 : 517-526.
de Melo A.,Carvalho A.,$β A.,Inhibitors A. .2006 .Chemical Structure and Biological Activity. Tetrahedron, 62 : 10277-10302.
Kerwin S.M. ChemBioOffice . .Ultra 2010 Suite 2010. , : .
Morris G.M.,Lim-Wilby M. Molecular,Docking M. Molecular .2008 .. , : 365-382.
Korb O.,Stützle T.,Exner T.E.,An Ant Colony Optimization Approach to Flexible Protein--Ligand Docking T.E. .2007 .. Swarm Intell, 1 : 115-134.
Humphrey ,Dalke A.,Schulten K. .1996 .VMD: Visual Molecular Dynamics. J. Mol. Graph, 14 : 33-38.
BIOvIA ,Syst Dassault . .. Discovery Studio Modeling Environment, 4 : .
Lee S.K.,Chang G.S.,Lee I.H.,Chung J.E.,Sung K.T. .2004 .; others The PreADME: Pc-Based Program for Batch Prediction of Adme Properties. EuroQSAR, 9 : 5-10.
Daina A.,Michielin O.,Zoete V. .2017 .SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, DrugLikeness and Medicinal Chemistry Friendliness of Small Molecules. Sci. Rep, 7 : 1-13.
Weiner P.K.,Kollman P.A.,AMBER P.A.,Interactions Their .1981 .: Assisted Model Building with Energy Refinement. A General Program for Modeling Molecules. J. Comput. Chem, 2 : 287-303.
Peukert W.,T. W. .2010 .An Improved Generalized AMBER Force Field (GAFF) for Urea. J. Mol. Model, 16 : 1427-1440.
Maier J.A.,Martinez C.,Kasavajhala K.,Wickstrom L.,Hauser K.E.,Simmerling C. .2015 .Ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from Ff99SB. J. Chem. Theory Comput, 11 : 3696-3713.
Berendsen H.J.C.,Postma J.P.M. van; van Gunsteren,DiNola W.F.,Haak J.R.,Molecular J.R. .1984 .Dynamics with Coupling to an External Bath. J. Chem. Phys, 81 : 3684-3690.
Vaught A. .1996 .Graphing with Gnuplot and Xmgr: Two Graphing Packages Available under Linux. Linux J, : 7-es.
Massova I.,Combined P.A. .2000 .Molecular Mechanical and Continuum Solvent Approach (MMPBSA/GBSA) to Predict Ligand Binding. Perspect. drug Discov. Des, 18 : 113-135.
Miller B.R.,McGee T.D.,Swails J.M.,Homeyer N.,Gohlke H.,Roitberg A.E. MMPBSA. .2012 .Py: An Efficient Program for End-State Free Energy Calculations. J. Chem. Theory Comput, 8 : 3314-3321.
Wadood A.,Ghufran M.,Hassan S.F.,Khan H.,S.S. H.,U. H.,Xylulose H. .2017 .-Phosphate Reductoisomerase for Treatment of Falciparum Malaria. Pharm. Biol, 55 : 19.
Yang Y.,Engkvist O.,Llinàs A.,Chen H. Beyond,Size H. Beyond .2012 .Toxicity for Druglike Compounds. J. Med. Chem, 55 : 3667-3677.
0

Citations

0

Downloads

31

Views